IL6 and COVID-19: A similar dysregulated immune response, marked by low levels of type I and III IFNs alongside elevated chemokines and high IL-6 expression, contributes to the pathogenesis of SARS-CoV-2 infection and the development of COVID-19 (Blanco-Melo et al., 2020).